FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Stapleton

Research Profile

Activities & Behaviors

Chemicals & Drugs

Procedures

Concepts & Ideas

Occupations

Family Practice

Geographic Areas

London

Disorders

Objects

Chewing Gum

Co-author Network

Publications

TOP 3
Leonie S Brose; Robert West; John A Stapleton
Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.
John A Stapleton; Robert West
A direct method and ICER tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: application to a new cytisine trial and other examples.
Jennifer A Fidler; John A Stapleton; Robert West
Variation in saliva cotinine as a function of self-reported attempts to reduce cigarette consumption.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Stapleton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Leonie S Brose; Robert West; John A Stapleton
Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice.
Mayo Clinic proceedings. Mayo Clinic 2013;88(3):226-33.
2012: John A Stapleton; Robert West
A direct method and ICER tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: application to a new cytisine trial and other examples.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2012;14(4):463-71.
2011: Jennifer A Fidler; John A Stapleton; Robert West
Variation in saliva cotinine as a function of self-reported attempts to reduce cigarette consumption.
Psychopharmacology 2011;217(4):587-93.
2009: John A Stapleton; Francis Keaney; Gay Sutherland
Illicit drug use as a predictor of smoking cessation treatment outcome.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2009;11(6):685-9.
2009: John A Stapleton
Trial comes too late as psychiatric side effects end hope for rimonabant.
Addiction (Abingdon, England) 2009;104(2):277-8.
2008: John A Stapleton
Breaking away from a narrow prescribing protocol for medicinal nicotine.
Addiction (Abingdon, England) 2008;103(4):564-5.
2008: John A Stapleton; Lucy Watson; Lucy I Spirling; Robert Smith; Andrea Milbrandt; Marina Ratcliffe; Gay Sutherland
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Addiction (Abingdon, England) 2008;103(1):146-54.
2007: John A Stapleton; Gay Sutherland; Colin O'Gara
Association between dopamine transporter genotypes and smoking cessation: a meta-analysis.
Addiction biology 2007;12(2):221-6.
2002: Richard M Palmer; John A Stapleton; Gay Sutherland; Paula Y Coward; Ron F Wilson; David A Scott
Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6).
European journal of clinical investigation 2002;32(11):852-7.
2001: David A Scott; Richard M Palmer; John A Stapleton
Validation of smoking status in clinical research into inflammatory periodontal disease.
Journal of clinical periodontology 2001;28(8):715-22.
2001: David A Scott; Richard M Palmer; John A Stapleton
Dose-years as an improved index of cumulative tobacco smoke exposure.
Medical hypotheses 2001;56(6):735-6.
2000: David A Scott; John A Stapleton; Richard M Palmer; Ron F Wilson; Gay Sutherland; Paula Y Coward; G Gustavsson; Edward W Odell; RN Poston
Plasma concentrations of reputed tumor-associated soluble CD44 isoforms (v5 and v6) in smokers are dose related and decline on smoking cessation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(11):1211-4.
2000: Martin Crook; David A Scott; John A Stapleton; Richard M Palmer; Ron F Wilson; Gay Sutherland
Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation.
European journal of clinical investigation 2000;30(10):861-5.
2000: David A Scott; John A Stapleton; Ron F Wilson; Gay Sutherland; Richard M Palmer; Paula Y Coward; G Gustavsson
Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking.
Blood cells, molecules & diseases 2000;26(3):255-8.
1999: John A Stapleton; A Lowin; MA Russell
Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectiveness.
Lancet 1999;354(9174):210-5.
1998: John A Stapleton; MA Russell; Gay Sutherland; Colin Feyerabend
Nicotine availability from Eclipse tobacco-heating cigarette.
Psychopharmacology 1998;139(3):288-90.
1998: John A Stapleton; G Sutherland; MA Russell
How much does relapse after one year erode effectiveness of smoking cessation treatments? Long-term follow up of randomised trial of nicotine nasal spray.
BMJ (Clinical research ed.) 1998;316(7134):830-1.
1997: Jonathan Foulds; John A Stapleton; N Bell; J Swettenham; Martin J Jarvis; MA Russell
Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers.
Drug and alcohol dependence 1997;44(2-3):105-15.
1995: G Sutherland; John A Stapleton; MA Russell; Colin Feyerabend
Naltrexone, smoking behaviour and cigarette withdrawal.
Psychopharmacology 1995;120(4):418-25.
1995: John A Stapleton; MA Russell; Colin Feyerabend; S M Wiseman; G Gustavsson; U Sawe; D Wiseman
Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice.
Addiction (Abingdon, England) 1995;90(1):31-42.
1993: MA Russell; John A Stapleton; Colin Feyerabend; S M Wiseman; G Gustavsson; U Sawe; P Connor
Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.
BMJ (Clinical research ed.) 1993;306(6888):1308-12.
1993: G Sutherland; MA Russell; John A Stapleton; Colin Feyerabend
Glycerol particle cigarettes: a less harmful option for chronic smokers.
Thorax 1993;48(4):385-7.
1992: G Sutherland; John A Stapleton; MA Russell; M J Jarvis; P Hajek; M Belcher; Colin Feyerabend
Randomised controlled trial of nasal nicotine spray in smoking cessation.
Lancet 1992;340(8815):324-9.
1989: Ann McNeill; M J Jarvis; John A Stapleton; MA Russell; J Richard Eiser; P Gammage; E M Gray
Prospective study of factors predicting uptake of smoking in adolescents.
Journal of epidemiology and community health 1989;43(1):72-8.
1989: Ann McNeill; M J Jarvis; John A Stapleton; R J West; A Bryant
Nicotine intake in young smokers: longitudinal study of saliva cotinine concentrations.
American journal of public health 1989;79(2):172-5.
1989: P H Jackson; John A Stapleton; MA Russell; R J Merriman
Nicotine gum use and outcome in a general practitioner intervention against smoking.
Addictive behaviors 1989;14(3):335-41.
1988: MA Russell; John A Stapleton; P Hajek; P H Jackson; M Belcher
District programme to reduce smoking: can sustained intervention by general practitioners affect prevalence?
Journal of epidemiology and community health 1988;42(2):111-5.
1987: MA Russell; John A Stapleton; P H Jackson; P Hajek; M Belcher
District programme to reduce smoking: effect of clinic supported brief intervention by general practitioners.
British medical journal (Clinical research ed.) 1987;295(6608):1240-4.
1986: P H Jackson; John A Stapleton; M A Russell; R J Merriman
Predictors of outcome in a general practitioner intervention against smoking.
Preventive medicine 1986;15(3):244-53.